CA2499320A1 - Gene de predisposition pour l'attaque chez l'homme, et procedes de traitement - Google Patents

Gene de predisposition pour l'attaque chez l'homme, et procedes de traitement Download PDF

Info

Publication number
CA2499320A1
CA2499320A1 CA002499320A CA2499320A CA2499320A1 CA 2499320 A1 CA2499320 A1 CA 2499320A1 CA 002499320 A CA002499320 A CA 002499320A CA 2499320 A CA2499320 A CA 2499320A CA 2499320 A1 CA2499320 A1 CA 2499320A1
Authority
CA
Canada
Prior art keywords
stroke
pde4d
nucleic acid
polypeptide
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002499320A
Other languages
English (en)
Inventor
Solveig Gretarsdottir
Sigridur Th. Reynisdottir
Gudmar Thorleifsson
Jeffrey R. Gulcher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Decode Genetics ehf
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/255,120 external-priority patent/US20040091865A1/en
Priority claimed from US10/419,723 external-priority patent/US20040014099A1/en
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2003/029906 external-priority patent/WO2004028341A2/fr
Publication of CA2499320A1 publication Critical patent/CA2499320A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne le rôle du gène humain PDE4D dans la prédisposition à l'attaque. L'invention concerne également des procédés de diagnostic, de prévision d'évolution clinique et de traitement pour l'attaque, reposant sur l'utilisation de polymorphismes dans le gène PDE4D en question.
CA002499320A 2002-09-25 2003-09-25 Gene de predisposition pour l'attaque chez l'homme, et procedes de traitement Abandoned CA2499320A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/255,120 US20040091865A1 (en) 2001-03-19 2002-09-25 Human stroke gene
US10/255,120 2002-09-25
US10/419,723 US20040014099A1 (en) 2001-03-19 2003-04-18 Susceptibility gene for human stroke; methods of treatment
US10/419,723 2003-04-18
US65012003A 2003-08-27 2003-08-27
US10/650,120 2003-08-27
PCT/US2003/029906 WO2004028341A2 (fr) 2001-03-19 2003-09-25 Gene de predisposition pour l'attaque chez l'homme, et procedes de traitement

Publications (1)

Publication Number Publication Date
CA2499320A1 true CA2499320A1 (fr) 2004-04-08

Family

ID=56290488

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002499320A Abandoned CA2499320A1 (fr) 2002-09-25 2003-09-25 Gene de predisposition pour l'attaque chez l'homme, et procedes de traitement

Country Status (4)

Country Link
EP (1) EP1552012A4 (fr)
JP (1) JP2006500068A (fr)
AU (1) AU2003278877A1 (fr)
CA (1) CA2499320A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109298133B (zh) * 2018-07-18 2021-07-13 重庆邮电大学 基于边缘通道校正的探测器模块生产良品率改进方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1146888A2 (fr) * 1998-10-15 2001-10-24 BioImage A/S Interventions therapeutiques specifiques obtenues par interference avec redistribution et ou ciblage
EP1141278B1 (fr) * 1998-12-30 2008-02-27 Oligos Etc. Inc. Inhibiteurs de la phosphodiesterase pde4d utilises a des fins therapeutiques
AU781519B2 (en) * 1999-06-25 2005-05-26 Memory Pharmaceuticals Corporation Cyclic AMP phosphodiesterase isoforms and methods of use
US20030054531A1 (en) * 2001-03-19 2003-03-20 Decode Genetics Ehf, Human stroke gene

Also Published As

Publication number Publication date
AU2003278877A1 (en) 2004-04-19
EP1552012A4 (fr) 2006-06-07
EP1552012A2 (fr) 2005-07-13
JP2006500068A (ja) 2006-01-05
AU2003278877A8 (en) 2004-04-19

Similar Documents

Publication Publication Date Title
US20050287551A1 (en) Susceptibility gene for human stroke; methods of treatment
AU2006260477B2 (en) Genetic variants in the TCF7L2 gene as diagnostic markers for risk of type 2 diabetes mellitus
US20050164220A1 (en) Susceptibility gene for human stroke: method of treatment
US20030054531A1 (en) Human stroke gene
US20050272051A1 (en) Methods of preventing or treating recurrence of myocardial infarction
CA2561901A1 (fr) Proteine d'interaction de voies du gene kv (kchip1) de diabete humain de type ii situee sur le chromosome 5
AU2003201728B2 (en) Gene for peripheral arterial occlusive disease
WO2003076658A2 (fr) Gene de predisposition a la maladie de parkinson idiopathique a apparition tardive
AU2003201728A1 (en) Gene for peripheral arterial occlusive disease
US20040014099A1 (en) Susceptibility gene for human stroke; methods of treatment
US20060141462A1 (en) Human type II diabetes gene-slit-3 located on chromosome 5q35
US7507531B2 (en) Use of 5-lipoxygenase activating protein (FLAP) gene to assess susceptibility for myocardial infarction
CA2499320A1 (fr) Gene de predisposition pour l'attaque chez l'homme, et procedes de traitement
US20050214780A1 (en) Human type II diabetes gene - Kv channel-interacting protein (KChIP1) located on chromosome 5
WO2005123964A2 (fr) Gene de susceptibilite pour les accidents vasculaires cerebraux chez l'humain et procedes de traitement
EP1585837A2 (fr) Gene humain de l'osteoporose

Legal Events

Date Code Title Description
FZDE Dead